CoChat

Disease progression modelling from preclinical Alzheimer’s disease (AD) to AD dementia

Open access
Cho, Soo Hyun, Woo, Sookyoung, Kim, Changsoo, Kim, Hee Jin, Jang, Hyemin, Kim, Byeong C., Kim, Si Eun, Kim, Seung Joo, Kim, Jun Pyo, Jung, Young Hee, Lockhart, Samuel, Ossenkoppele, Rik, Landau, Susan, Na, Duk L., Weiner, Michael, Kim, Seonwoo, Seo, Sang Won · 2021 · Scientific Reports
Cited by 38

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

To characterize the course of Alzheimer’s disease (AD) over a longer time interval, we aimed to construct a disease course model for the entire span of the disease using two separate cohorts ranging from preclinical AD to AD dementia. We modelled the progression course of 436 patients with AD continuum and investigated the effects of apolipoprotein E ε4 (APOE ε4) and sex on disease progression. To develop a model of progression from preclinical AD to AD dementia, we estimated Alzheimer’s Disease Assessment Scale-Cognitive Subscale 13 (ADAS-cog 13) scores. When calculated as the median of ADAS-cog 13 scores for each cohort, the estimated time from preclinical AD to MCI due to AD was 7.8 years and preclinical AD to AD dementia was 15.2 years. ADAS-cog 13 scores deteriorated most rapidly in women APOE ε4 carriers and most slowly in men APOE ε4 non-carriers (p < 0.001). Our results suggest that disease progression modelling from preclinical AD to AD dementia may help clinicians to estimate where patients are in the disease course and provide information on variation in the disease course by sex and APOE ε4 status.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-83585-3

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 38

Metadata

Authors
Cho, S. H., Woo, S., Kim, C., Kim, H. J., Jang, H., Kim, B. C., Kim, S. E., Kim, S. J., Kim, J. P., Jung, Y. H., Lockhart, S., Ossenkoppele, R., Landau, S., Na, D. L., Weiner, M., Kim, S., & Seo, S. W.
Venue
Scientific Reports
Published
2021-02-18
Volume
11
Issue
1
Pages
4168-4168
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3132707226
Cited by
38
References
14
FWCI
3.17
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Disease progression modelling from preclinical Alzheimer’s disease (AD) to AD dementia. https://app.cochat.ai/papers/10.1038/s41598-021-83585-3
The paper
Cho, S. H., Woo, S., Kim, C., Kim, H. J., Jang, H., Kim, B. C., Kim, S. E., Kim, S. J., Kim, J. P., Jung, Y. H., Lockhart, S., Ossenkoppele, R., Landau, S., Na, D. L., Weiner, M., Kim, S., & Seo, S. W. (2021). Disease progression modelling from preclinical Alzheimer’s disease (AD) to AD dementia. Scientific Reports. https://doi.org/10.1038/s41598-021-83585-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.